ECHO Diabetes program for Federally Qualified Health Centers
Official title: Extension for Community Health Outcomes (ECHO) Diabetes Federally Qualified Health Centers (FQHCs)
Run by University of Florida · NCT07417865 · Data updated 2026-11-12
This program will test whether a 6-month tele-education series for primary care teams at Federally Qualified Health Centers helps lower very high HbA1c rates and increases use of diabetes technology in adults with diabetes.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 18 (estimated) |
| Sponsor | University of Florida Academic / other |
| Locations | 2 sites (Miami, Florida and 1 other locations) |
| Status | Recruiting |
| Started | January 22, 2026 |
| Main results expected | July 31, 2028 |
| Study ends | July 31, 2028 |
| Registry record updated | February 18, 2026 |
| Trial ID | NCT07417865 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are Federally Qualified Health Centers that are members of Health Choice Network or AllianceChicago and their adult patients with diabetes whose de-identified aggregate data can be shared for monitoring.
✕Probably not a fit
Patients served at clinics that are not FQHCs or not part of HCN or AllianceChicago, and those under 18 who are excluded from the adult aggregate datasets, are unlikely to benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The program uses a hub-and-spoke tele-education model delivering one-hour ECHO sessions twice monthly over six months to PCP teams at participating FQHCs, plus onboarding, real-time case support, and an online resource library. The multidisciplinary hub includes endocrinologists, CDCES, a psychologist, dietitian, exercise physiologist, PCPs, and health services researchers and offers CME credits. Eighteen spokes drawn from two Health Center Controlled Networks will be randomized into three staggered cohorts in a stepped-wedge design, with covariate-constrained randomization guiding assignment. Program effects will be measured using provider pre/post surveys and center-level aggregate clinical data, focusing on glycemic control and technology adoption.
Why it matters
Potential benefit: If successful, FQHC primary care teams could better manage diabetes so fewer patients have very high HbA1c and more patients gain access to CGM and insulin pumps.
How similar studies have gone: Project ECHO programs, including earlier ECHO Diabetes efforts, have generally improved provider knowledge and care processes, though patient-level outcome effects have been mixed across studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Federally Qualified Health centers (spokes) are eligible to participate that are part of Health Choice Network (HCN) or Alliance Chicago (AC). All people living with diabetes 18 and older are included in aggregate data sharing to evaluate outcomes. \- Exclusion Criteria: * Non FQHC, not part of HCN or AC
Where it's running
-
Health Choice Network
Miami, Florida, United States Recruiting -
Alliance Chicago
Chicago, Illinois, United States Recruiting
Study contacts
- Principal investigator: Ashby F Walker, Ph.D. — University of Florida
- Study coordinator: Ashby F Walker, Ph.D.
- Email: afwalker@ufl.edu
- Phone: 352-273-8278
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
New virtual care pathway for older adults with chronic diseases
A teleconsultation-based care pathway for adults 60+ with hypertension, diabetes, or dyslipidemia to see if it’s feasible and cost-saving in Malaysian primary care compared with usual clinic visits.
-
Benefits of Retained Insulin for Good Health in Diabetes
This study tests whether preserving or restoring a person’s own insulin production can improve quality of life and blood sugar control for people who need insulin to manage diabetes.
-
Improving Care for underserved older Black patients with cardiovascular and other chronic conditions
This study tests a culturally tailored approach to patient-centered care for older African American patients with cardiovascular disease and other conditions who receive care at a community hospital.
-
Myokines in metabolic and endocrine diseases linked to sarcopenia
This study tests whether myokines can serve as biomarkers or drivers of sarcopenia and sarcopenic obesity in people with metabolic or endocrine diseases.
-
Miniature breath sensors to detect hypo- and hyperglycemia in young people with diabetes
A small breath-sensor device will try to see if specific breath compounds can signal low or high blood sugar in youths with diabetes.
-
Polypill Approach for Multiple Cardiovascular Risk Factors
Researchers are testing a fixed-dose pill strategy to help people aged 50–75 with high blood pressure, high cholesterol, and diabetes see if it lowers their heart-disease risk and reduces future events.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.